Breast cancer specialist Dr. Sara Giordano says some patients can now avoid a treatment that causes short-term side effects and can, in some cases, lead to long-term problems.
International trial leads to big change in treatment for hundreds of cancer patients
Hollings Cancer Center has partnered with other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer.
Cancer centers rally against HPV-related cancers
Behind every patient stands a multidisciplinary team of cancer specialists who work together to determine the best care plan for each patient, and across our campus leading scientists and researchers work daily to unlock the clues to cancer.
Sara Giordano, M.D., a breast cancer specialist at MUSC Health, calls it exciting to be able to omit chemotherapy for a lot of women with early-stage breast cancer. The change is based on the findings of a major international study called TAILORx.
Join us for the 8th annual Swing For A Cure Fundraiser on June 22 & 23. The kick-off party with auctions will be held at Harborside East on Friday, June 22, and the golf tournament will be held at Patriots Point Links on Saturday, June 23.
This year, more breakthroughs will be discovered. More cancer patients will find hope. And Hollings Cancer Center will be on the leading edge of offering better options to patients. As a cancer center that combines patient care and research, Hollings brings together over 180 physicians and scientists who are driving the discoveries that will lead to tomorrow’s treatments.
Quality & Awards
The only National Cancer Institute-Designated Cancer Center in South Carolina, Hollings is at the forefront of cancer research. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public, and to establish outreach services for underserved populations.
- Senator Ernest "Fritz" HollingsHealth Focus: SC Public Radio
Bobbi Conner talks with Dr. Chrystal Paulos about cancer research related to adoptive cell transfer immunotherapy.Hollings in the Community
As one of the leading cancer treatment centers in the Southeast, Hollings Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we serve. Our team of more than 60 sub-specialists – each concentrating on a specific discipline of cancer treatment and care – works with individual patients to develop customized treatment programs that target a broad range of conditions. Our specialists work together as a team, often meeting with patients under the same roof on the same day. We are striving to deliver the highest level of care in the best way possible.
Personalized patient care is at the center of everything we do. And no one tells the story better than our patients themselves. Meet some of our patients and hear about their cancer journey.
Patients may be referred to Hollings by calling MEDULINE at 843-792-2200 or 800-922-5250, MUSC’s dedicated consultation line open 24/7 exclusively for health care professionals or through the online Patient Referral Portal.
Find a Nurse Navigator
Hollings Cancer Center is home to more than 120 scientists conducting research and collaborating on better ways to prevent, detect, diagnose and treat this complex disease. As one of 70 National Cancer Institute-Designated Cancer Centers, Hollings continues to attract top cancer researchers from leading institutions across the country who are conducting research in the community, laboratory and clinic.